Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers. [PDF]
PLoS ONE, 2011 The CA 19-9 assay detects a carbohydrate antigen on multiple protein carriers, some of which may be preferential carriers of the antigen in cancer. We tested the hypothesis that the measurement of the CA 19-9 antigen on individual proteins could improve ...
Tingting Yue +13 more
doaj +2 more sources
Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseases. [PDF]
Proteomics, 2011 The current best serum marker for pancreatic cancer, CA 19‐9, detects a carbohydrate antigen on multiple protein carriers. Better knowledge of the protein carriers of the CA 19‐9 antigen in various disease states may lead to improved diagnostic tests. To
Yue T +9 more
europepmc +2 more sources
Intralobar Pulmonary Sequestration and Increased Serum CA 19-9 [PDF]
European Journal of Case Reports in Internal Medicine, 2017 Intralobar pulmonary sequestration is an uncommon congenital lung anomaly which consists of a mass of normal lung tissue not connected to the normal tracheobronchial tree and supplied by an anomalous systemic artery.
Massimo Montalto +4 more
doaj +3 more sources
The prognostic value of postoperative tumor marker conversion for gastric cancer [PDF]
Korean Journal of Clinical Oncology, 2020 Purpose Preoperative positivity of serum tumor markers has been associated with poor long-term survival among patients with gastric cancer. However, there have been a considerable number of patients who have experienced a normalization of tumor markers ...
Jeongju Noh, Ki Bum Park, Oh Kyoung Kwon
doaj +1 more source
Asian Journal of Surgery, 2021 Background: We assessed the use of serum concentrations of carbohydrate antigen (CA) 19–9 and carcinoembryonic antigen (CEA) measured during the preoperative diagnostic workup as prognostic factors for survival in patients with periampullary carcinoma ...
Sang Hun Park +3 more
doaj +1 more source
CA 19-9 in Ovarian Immature Teratoma- A Potential Tumour Marker or A Masquerade? [PDF]
Journal of Clinical and Diagnostic Research, 2022 Carbohydrate antigen 19-9, also known as Cancer Antigen (CA 19-9) is a tumour marker found elevated in certain ovarian tumours. Although, reports of its association with mature teratoma are considerable, little is mentioned about its association with ...
Julie H John +4 more
doaj +1 more source
Journal of Evidence-Based Integrative Medicine, 2023 Background: Some epithelial tumors express the carbohydrate antigen 125 (Cancer antigen-125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors.
Abd AlRahman Mohammad Foda MD +5 more
doaj +1 more source
Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer [PDF]
, 2006 In pancreatic cancer ( PC) accurate determination of treatment response by imaging often remains difficult. Various efforts have been undertaken to investigate new factors which may serve as more appropriate surrogate parameters of treatment efficacy ...
Anderson JS +48 more
core +1 more source
B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches. [PDF]
, 2020 Despite considerable advances in the treatment of multiple myeloma (MM) in the last decade, a substantial proportion of patients do not respond to current therapies or have a short duration of response.
Chari, Ajai +4 more
core +1 more source
Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: Pretreatment levels or kinetics during chemotherapy? [PDF]
, 2007 Background: The carbohydrate antigen 19-9 (CA 19-9) is currently the most widely used serum tumor marker in pancreatic cancer (PC). CA 19-9 pretreatment levels as well as CA 19-9 kinetics during systemic chemotherapy can provide prognostic information ...
Boeck, Stefan +5 more
core +1 more source